Second neoplasms in acute lymphoblastic leukemia

The authors reviewed 61 reported cases of second neoplasms in acute lymphoblastic leukemia (ALL), including 17 patients with ALL followed by another type of acute leukemia, 12 patients with ALL followed by chronic myelocytic leukemia, 19 patients with ALL followed by lymphoma, and 13 patients with A...

Full description

Saved in:
Bibliographic Details
Published in:Cancer 1983-11, Vol.52 (9), p.1712-1719
Main Authors: Zarrabi, M. Hosein, Rosner, Fred, Grünwald, Hans W.
Format: Article
Language:English
Subjects:
Acute Disease
Adolescent
Adult
Age Factors
Biological and medical sciences
Brain Neoplasms - pathology
Child
Child, Preschool
Combined Modality Therapy
Digestive System Neoplasms - pathology
Female
Hematologic and hematopoietic diseases
Humans
Infant
Leukemia, Lymphoid - pathology
Leukemia, Lymphoid - therapy
Leukemia, Myeloid - pathology
Leukemias. Malignant lymphomas. Malignant reticulosis. Myelofibrosis
Lymphoma - pathology
Male
Medical sciences
Middle Aged
Neoplasms, Multiple Primary - etiology
Risk
Thyroid Neoplasms - pathology
Time Factors
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The authors reviewed 61 reported cases of second neoplasms in acute lymphoblastic leukemia (ALL), including 17 patients with ALL followed by another type of acute leukemia, 12 patients with ALL followed by chronic myelocytic leukemia, 19 patients with ALL followed by lymphoma, and 13 patients with ALL followed by other solid tumors. From a review of the literature, it is believed that there is no firm evidence yet that patients with ALL, intensively treated with chemotherapy and/or radiotherapy, are at increased risk of developing therapy‐related second neoplasms. Because the number of cases reported is small, there is even insufficient data to firmly suggest that acute myeloblastic leukemia, following intensive therapy for ALL, occurs in a higher‐than‐expected frequency.
ISSN:0008-543X
1097-0142
DOI:10.1002/1097-0142(19831101)52:9<1712::AID-CNCR2820520927>3.0.CO;2-I